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Early experiments of Flexner and Lewis  (1),  Levaditi and Land- 
steiner  (2),  and RSmer and Joseph  (3)  showed that monkeys once 
recovered from poliomyelitis are immune to subsequent intracerebral 
inoculations of poliomyelitis virus.  This immunity was apparent no 
matter  how slight  had  been  the  symptoms  of  the initial infection. 
The refractory state  was of long duration  and was absolute within 
the limit  of infecting doses  employed.  These  same workers noted 
that  sera  of  convalescent monkeys, when mixed with poliomyelitis 
virus in vitro, rendered the material, otherwise infective, inactive when 
introduced intracerebrally in test  animals. 
These observations became the basis for numerous efforts to immunize animals 
against  experimental  poliomyelitis.  Flexner  and  Lewis  (4)  injected  monkeys 
subcutaneously with living active virus, beginning with a dose of 0.05 cc.  This 
amount was given daily for four days and the series Was repeated twice with  a 
four day rest period between  each individual  set of injections.  After the  last 
interval the animals received on successive days 0.1, 0.5, and 1.0 cc. of virus, and 
after one month 5.0 cc.  A week's rest period then followed, after which time the 
animals  were  tested  intracerebrally  with  2.0  cc.  of fresh  Berkefeld  filtrate  of 
poliomyelitis virus.  Control monkeys which received 0.1 to 0.01  cc. of a similar 
filtrate  intracerebrally  developed  typical poliomyelitis,  whereas  the vaccinated 
animals remained free  from symptoms. 
Levaditi and Landsteiner (5) attempted to immunize monkeys by a single sub- 
cutaneous inoculation of 0.5  cc. of virus suspension previously heated  to 50°C. 
for 30 minutes.  They failed to produce any immunity by this  treatment.  In 
another experiment glycerinated virus was heated to 50°C. for 2 hours; this heated 
virus was still active in producing disease when inoculated intracerebrally,  but 
did not infect when given daily in subcutaneous doses of 2 cc. each over a period of 
one month.  Nine days after the last subcutaneous injection two treated monkeys 
were tested intracerebrally.  One of these showed slight prodromal symptoms of 
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poliomyelitis and the second gave no evidence of disease,  whereas the control 
developed typical poliomyelitis. 
Kraus (6)  attempted the attenuation of poliomyelitis virus by phenolization 
and found that virus treated by 1 per cent phenol was rendered ineffective in four 
days, even when inoculated subduraUy.  He then endeavored to immunize mon- 
keys by subcutaneous injection of 5 to 10 cc. of virus treated with varying concen- 
trations of phenol for different periods of time.  Of fifteen animals subjected to 
intracerebral  test inoculations,  twelve were immune.  It is interesting  to note 
that three animals immuvi~d with virus treated with 1.5 per cent phenol for five 
days--a procedure calculated by Kraus to render virus inactive---were completely 
protected.  In a second communication Krans (7) reports results on two animals, 
one of which received 5 cc. of fresh virus cord emulsion subcutaneously, followed 
fifteen ~lays  later by 6 cc. of 0.5 per cent phenolized cord; a second monkey received 
6 cc.  of 0.5 per cent phenolized cord.  Ten days later both monkeys resisted a 
test intracerebral inoculation with paper filtrate, whereas a control developed the 
typical disease. 
Olaf Thomsen (8) gave monkeys daily sub-infective inoculations subcutaneously 
for twelve days and subsequently at weekly intervals, 0.06, 0.2, 0.4,  1.0, and 2.0 
cc. of virus suspension.  All animals were then resistant to intracerebral test but 
the author states that every animal showed symptoms such as excitement, tremor, 
and ataxia, during immunization.  A second group was treated, using consider- 
ably smaller immunizing doses; of this series no animal showed symptoms during 
the immunizing procedure, yet all resisted test inoculation.  The initial ~mmuniz- 
ing dose in this second series was only one hundredth of the estimated intracerebral 
infecting dose. 
Zappert, Wiesner, and Leiner (9)attempted to  immunize four  monkeys  by 
means of subcutaneous injections of gradually increasing doses  of active virus 
emulsions.  During the ~ramunization,  two of the animals died of intercurrent 
infection, one of typical poliomyelitis, and one of a supposedly marantic type of 
the disease.  They attempted to induce an artificial immunity in one animal by 
the use of phenolized virus.  The monkey developed the disease during the treat- 
ment designed to immunize against it. 
Flexner and Amoss (10) described a so-called immunizing strain of poliomyelitis 
virus.  To free a contaminated glycerinated brain from organisms, the tissue was 
immersed in 0.5 per cent phenol for a few hours and replaced in glycerine.  This 
procedure was  repeated once.  The  animals were subsequently  infected  with 
1.0 cc. of 10 per cent suspension,  their disease running an average eleven day 
course.  In a series of passages the virulence of the strain decreased until a point 
was reached where the monkeys showed very few symptoms,--such as ataxia, 
tremor,  and  slight  convulsive seiz~ares--recovered,  and  were  subsequently im- 
mune to strong virus. 
Abramson and Gerber (11) treated emulsions of brain and cord of poliomyelitic 
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when introduced subcutaneously in monkeys.  They then endeavored to immunize 
by heated virus.  On five successive days monkeys were injected with cord emul- 
sion; the emulsion was heated to 55°C. for thirty minutes the first and second day, 
to 45°C. for thirty minutes the third day, to 37°C. for thirty minutes the fourth, 
and was used without preliminary heating on the fifth day.  The dose was 5 cc. 
on each day.  Three weeks after treatment the animals were bled and their sera 
tested for its power to neutralize virus.  Of eight sera, three  neutralized, four 
led to prolonged incubation period, and one failed.  Intracerebral tests indicated 
that five of the treated monkeys were resistant to three  to six minimum lethal 
doses of virus, whereas three proved susceptible. 
In another series of three monkeys, Abramson and Gerber gave daily injections 
subcutaneously of 5 cc. of 10 per cent cord emulsion previously heated to 55°C. 
for one hour.  On intracerebral test three weeks later, all developed poliomyelitis; 
of the three sera tested, one monkey showed  no symptoms and two a  delayed 
incubation period but eventuaily developed the disease. 
McKinley and Larson (12) inoculated monkeys intracerebraily with 0.15  cc. 
of filtrate of a mixture of 5 per cent emulsion of castor oil soap and virus emulsion. 
The animals remained weU and later resisted intracerebral inoculation of 0.7 cc. 
virus filtrate.  Four more monkeys received 4 ce. of the virus-soap mixture intra- 
peritoneally; none developed poliomyelltis, whereas a control with virus aione be- 
came paralyzed in a typical manner.  Eleven days after the intraperitoneal virus. 
soap treatment, all four monkeys were tested intracerebrally; three remained weU 
and one developed poliomyelitis. 
The largest and most varied series of tests of poliomyelitis immlmlzation is that 
of Aycock and Kagan  (13).  These investigators attempted to immunize with 
virus attenuated by various methods.  The old experiments of Kraus with phe- 
nolized  virus were repeated using material treated with 1.0, 0.75, 0.50, and 0.25 
per cent phenol.  The mixtures were kept for seven days in the icebox.  Monkeys 
were then given four injections every other day of from 8 to 10 cc., beginning 
with the 1.0 per cent phenolized virus, and ending with the 0.25 per cent.  Of 
four anlmals so treated, two became paralyzed during the process of vaccination, 
one failed to resist intracerebral test inoculation, and one resisted.  In a second 
experiment monkeys were injected subcutaneously with virus cords dried over 
caustic po.tash from one to twenty-six days.  Two of six monkeys became para- 
lyzed during treatment, two failed to show protection on intracerebral inoculation, 
and two proved resistant.  Next, virus cord was exposed to different glycerol- 
water dilutions (5 to 50 per cent glycerol) for seven months at ice box temperature. 
Monkeys were injected daily subcutaneously, beginning with virus from 5 per cent 
glycerol and ending with 50 per cent glycerol.  Three animals developed paralysis 
during imm~mDation;  three failed to resist an intracerebral test; one resisted.  In 
another group, virus in agar was introduced subcutaneously in eight snlmals; the 
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from three to seventeen injections; two animals became paralyzed during treat- 
ment, two failed to show subsequent immunity, and two resisted. 
In a fifth experiment virus was introduced intracutaneously in from 1 to 2 cc. 
amounts but was distributed in 0.05 cc. blebs, thus making from twenty to forty 
piqures each day of inoculation.  The total amount of virus injected ranged from 
5 to 76 cc. in six to forty-three inoculations, given during a period ranging from 
fifteen days to five months.  Twelve monkeys were used; one became paralyzed 
during treatment; one failed to resist intracerebral inoculation; ten resisted one 
intracerebral test, but of these, two failed to withstand a second such test.  Serum 
from eight resistant monkeys neutralized virus twenty-one times; one monkey's 
serum protected in one test, although the animal itself was not immune to intrao 
cerebral test inoculation. 
From the review of the literature,  it is apparent that the results of 
experiments  designed  to  immunize  monkeys  against  poliomyelitis 
have been inconclusive.  Two facts stand out clearly; first,  that it is 
impossible to protect monkeys by the use of killed virus, and  second, 
that  a  definite  though  inconstant  resistance  to  poliomyelitis  can  be 
brought  about by the  intradermal  and  subcutaneous  introduction of 
the living virus.  It was therefore deemed advisable to  compare the 
results  of the  two  routes  of inoculation  in order  to  gain information 
as to their relative efficacy.  The following experiments were carried 
out  with  this  point  in  view. 
Experimental. 
Eight monkeys (Table I) were immunized by the intracutaneous route, follow- 
ing in general the procedure of Aycock and Kagan.  The injections were made 
biweekly and the total amount of a single  day's dosage (1.5 to 2.0  cc. of 5 per 
cent glycerolated virus) was distributed in some twenty small blebs.  The duration 
of the immunizing period was variable, lasting from three to five months.  The 
total amounts of virus administered ranged from 42 to 66 cc.  Before intracere- 
bral test inoculation, all animals were bled in order to test their sera for virus- 
neutralizing power.  The test inoculations were made with fresh virus injected 
intracerebrally in doses of 0.5 cc. of 5 per cent suspension.  During the immuniza- 
tion period all animals were observed daily in order to detect possible abortive 
symptoms of disease and were exercised  to bring out masked weaknesses. 
Eight more monkeys (Table II) were treated in an analogous fashion but re- 
ceived their immunizing virus subcutaneously instead of intracutaneously.  The 
amounts of virus used and the time intervals were comparable with those of the 
intracutaneous series, and bleedings  and test inoculations were done in the same 
manner.  Both tests for active immunity and for passive serum protection were 
rigorously controlled.  The results in the two series are best seen in the tables. ~F.  W.  STEWART  AND  C.  P.  R.I:{OADS  963 
DISCUSSION. 
The primary purpose of this series of experiments was to determine 
whether the intradermal or the subcutaneous introduction of polio- 
myelitis virus was most effective in protecting monkeys against virus 
inoculation.  Reference to Tables I  and II shows that the degree of 
immunity produced is strikingly in favor of the intradermal method. 
Of the eight animals subjected to that procedure, all but one showed 
slight symptoms of the disease when tested by intracerebral inocula- 
tion of an amount of virus sufficient to cause characteristic poliomye- 
litis in the controls.  No animal, however, developed more than the 
mildest abortive symptoms, such as tremor or excitement.  No defi- 
nite paralysis  developed in any instance, and no  subsequent muscle 
atrophy was observed.  These results are sharply at  variance with 
those of intracerebral  inoculation  of the group of monkeys treated 
by subcutaneous inoculation of virus.  Four of the eight animals of 
this  series developed typical poliomyelitis which progressed to pros- 
tration  in  two  instances, and to well-marked paralysis in the other 
two.  The remaining four animals proved to be completely refractory 
to the intracerebral tests. 
During  the  process  of  immunization,  the  animals  were  closely 
observed to  determine whether or not  they developed an  abortive 
form of poliomyelitis which might explain the subsequent immunity 
to the disease.  Wicl~man (14), during the Swedish epidemic of 1905, 
noticed a considerable number of cases in man, which showed slight, 
transient  symptoms,  without  developing  the  outspoken  disease. 
Caverly (15), in the Vermont epidemic of 1904, saw six children with 
fever, nausea, and convulsions, whose illness never progressed further. 
Medin (16) also observed such abortive cases.  Aycock (17) mentions 
the possibility that mild attacks of poliomyelitis are responsible for 
the  development of  immunity.  In  view of  these  observations  we 
were on the alert to detect slight symptoms referable to the treatment. 
However, no deviation from the normal was discovered.  Subcutane- 
ous inoculation of virus has in our experiments on eight animals failed 
to produce the disease,  although it has given rise to poliomyelitis in 
the hands of others (Flexner and I~ewis, Aycock, and Olaf Thomsen). 
As evidence of th~ relative safety of intradermal inoculation of ~rus, 
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has been given intracutaneously at one time without produdng symp- 
toms, while 0.005 cc. of Berkefeld filtrate of virus of the same strain 
inoculated intracerebrally consistently produced characteristic polio- 
myelitis in six  days. 
The question of the degree of protection conferred by the treatment 
proved to be an extremely interesting one.  It has often been observed 
that  different strains  of poliomyelitis virus vary markedly in their 
power to produce the disease  in susceptible animals.  We therefore 
attempted to detect degrees of immunity by testing animals by intra- 
cerebral inoculation, not only with virus of the strain with which they 
had  been  immunized, but  also  with other  strains.  Thus  monkeys 
treated with the M.A. strain of virus were tested with a fairly recent 
virus isolated in Vermont by Aycock, and animals immunized with 
Aycock strain  were tested with the  i~I.A, virus.  The  difference in 
the results is well-marked; monkeys treated in exactly the same way 
proved totally resistant  to the relatively weak M.A.  virus and not 
totally immune to the stronger Aycock virus.  A group of three ani- 
mals  immunized with  M.A.  strain  is  described  in  Table  III.  All 
withstood subsequent intracerebral inoculation with both  M.A. and 
Aycock virus but one of the three developed typical poliomyelitis on 
inoculation  with  a  very  active  pooled,  mixed  virus  derived  from 
material of the original M.A. and K. strains which had been preserved 
in glycerol since 1920 (18, 19,  20). 
That the immunity induced in the monkeys in these experiments is 
relative only, is more strikingly shown by tests employed to  determine 
the power of the sera to neutralize the virus.  The results of these 
determinations are shown in Table IV.  The sera of Monkeys 1, 2, 
and 3 were pooled in one and those of 9, 10, and 11 in a second group. 
These two mixed sera neutralized, as  was to beexpected,  since on 
intracerebral  test  the  monkeys  had  proved  resistant.  Moreover, 
Sera 6, 7, and 8, derived from monkeys which had presented definite 
symptoms of poliomyelitis on intracerebrai inoculation, were found 
also  to  neutralize completely a  small,  though ample dose,  approxi- 
mately 50 M.L.D. of a highly active virus filtrate of the pooled mixed 
virus strain.  The results of the neutralization tests of sera  12  and 
16  are  especially  significant.  Although  the  monkeys  from  which 
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inoculation of the active pooled virus, their sera neutralized the same 
potent material.  It is interesting to note that in one instance of the 
16 animals tested did the serum fail to exhibit neutralizing power. 
The results of the serum neutralization tests show that degrees of 
immunity to poliomyelitis virus exist not only in monkeys but suggest 
that the same condition exists in man.  The employment of relatively 
small doses of filtrate of a virus strain, whose potency is quite constant, 
brings out degrees of specific protection in monkeys.  Such variations 
would have been totally obscured by the ordinary means of determin- 
ing immunity by the intracerebral inoculation of considerable amounts 
of suspension of virus possessing  varying degrees of infective power. 
It  is  conceivable that  the past  failures  of  certain  efforts  to  induce 
immunity in monkeys may be explained, not by the  inadequacy of 
the methods employed, but rather by the overwhelming inoculation 
which the  animal was required to  withstand,  doubtless  far  greater 
than that to which any human would be exposed.  The intracerebral 
test inoculation particularly, with its associated damage to nervous 
tissue, makes demands upon the immune reaction of an animal many 
times greater than that arising in any natural method of  infection. 
CONCLUSIONS. 
I.  The introduction of considerable amounts of living, active polio- 
myelitis virus into the skin and subcutaneous tissue of monkeys pro- 
tects  the animals against intracerebral inoculations of  similar virus 
material. 
2.  The  degree of  protection  conferred by  intradermal  is  greater 
than by subcutaneous injection. 
3.  During intradermal and subcutaneous inoculations, no local or 
general pathological signs were observed. 
4.  The degree of protection produced by the immunization methods 
used is not absolute,  since a  percentage of the inoculated monkeys 
respond to intracerebral injections of highly potent virus. 
5.  The sera of the animals inoculated intradermally or subcutane- 
ously neutralized poliomyelitis virus in vitro, irrespective of the result 
of intracerebral inoculation, in all except one instance. 
6.  The power of the serum of treated monkeys to neutralize virus P.  w.  SteWARt ANO  C.  1'.  z~ao~ms  973 
in vitro is a  more delicate test of immunity than is the intracerebral 
inoculation. 
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